Detalhe da pesquisa
1.
Association with HLA-DRß1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis.
Hum Mol Genet
; 31(14): 2471-2481, 2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094092
2.
Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profiles.
Rheumatology (Oxford)
; 62(11): 3680-3689, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929918
3.
Metabolomics analysis identifies a lipidomic profile in treatment-naïve juvenile dermatomyositis patients vs healthy control subjects.
Rheumatology (Oxford)
; 61(4): 1699-1708, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34185053
4.
Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups.
Ann Rheum Dis
; 78(7): 996-1002, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31138531
5.
Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.
Ann Rheum Dis
; 77(2): 241-250, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29084729
6.
An Approach to Compensation Plans for Physician Faculty in Academic Pediatric Departments.
J Pediatr
; 262: 113511, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37244572
7.
Two Steps Forward, One Step Back: The Complexity of Accurately Defining and Measuring Clinical Activity in Academic Pediatrics.
J Pediatr
; 259: 113446, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120130
8.
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Ann Rheum Dis
; 76(5): 782-791, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28385804
9.
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.
Ann Rheum Dis
; 76(12): 1955-1964, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29079590
10.
Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab.
Rheumatology (Oxford)
; 56(2): 247-254, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27837048
11.
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects.
Rheumatology (Oxford)
; 56(11): 1884-1893, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28977549
12.
Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups.
Ann Rheum Dis
; 75(8): 1558-66, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26362759
13.
Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.
Rheumatology (Oxford)
; 55(6): 991-9, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26888854
14.
Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab.
Clin Exp Rheumatol
; 33(5): 655-63, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26446265
15.
Immunological biomarkers in dermatomyositis.
Curr Rheumatol Rep
; 17(11): 68, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26404949
16.
Biologic predictors of clinical improvement in rituximab-treated refractory myositis.
BMC Musculoskelet Disord
; 16: 257, 2015 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26382217
17.
Recent advances in juvenile idiopathic inflammatory myopathies.
Curr Opin Rheumatol
; 26(6): 671-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25160931
18.
Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.
Ann Rheum Dis
; 73(3): 557-66, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23436914
19.
Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis.
Arthritis Rheum
; 65(8): 2201-10, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23686519
20.
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.
Arthritis Rheum
; 65(2): 314-24, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23124935